bioAffinity Technologies
BIAF
7 hedge funds and large institutions have $177K invested in bioAffinity Technologies in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 0 closing their positions.
17% more funds holding
Funds holding: 6 → 7 (+1)
0% less ownership
Funds ownership: 0.04% → 0.04% (-0%)
9% less capital invested
Capital invested by funds: $193K → $177K (-$16.5K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.54K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$8.72K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$4.25K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $79.9K | – | – | – |
|
|
2
Two Sigma Investments
New York
| $40K | -$8.72K | -158 | -18% |
|
3
State Street
Boston,
Massachusetts
| $32.2K | – | – | – |
|
4
Creative Planning
Overland Park,
Kansas
| $22.1K | – | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $2.53K | +$2.54K | +46 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $174 | -$4.25K | -77 | -96% |
|
7
Wells Fargo
San Francisco,
California
| $66 | – | – | – |
|
BIAF Hedge Fund Activity: Q2 2023 in Review
7 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAF) for Q2 2023, worth a combined $177K — down 8.5% from $193K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIAF positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $2.54K. The largest seller was Two Sigma Investments, cutting an estimated $8.72K.
- 7 institutional investors held bioAffinity Technologies (BIAF) as of Q2 2023, up from 6 in Q1 2023.
- Funds reported $177K of bioAffinity Technologies stock for Q2 2023, down 8.5% quarter-over-quarter.
- 1 fund opened new bioAffinity Technologies positions in Q2 2023 and 0 closed out, a net change of +1 holder.
- The largest bioAffinity Technologies buyer in Q2 2023 was Tower Research Capital (TRC), an estimated $2.54K added.
- The largest bioAffinity Technologies seller in Q2 2023 was Two Sigma Investments, an estimated $8.72K sold.
Based on aggregated 13F filings for Q2 2023.